Understanding HER2 Low Breast Cancer

Listen Now

Topics Covered

• Overview of HER2 Low Breast Cancer, Including What is HER2 Status
• Diagnostic Testing: What is an Immunohistochemistry (IHC) Test or Fluorescence In Situ Hybridization (FISH) Test
• The Role of the Pathologist
• The Role of the Genetic Counselor
• Standard Treatment Options, Including Targeted Therapy
• How Biomarker Testing Informs Treatment Decisions
• New Targeted Treatments
• Updates on Investigational New Drugs in Clinical Trials: How Research Contributes to Treatment Options
• What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort & Pain
• Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns for HER2 Low Breast Cancer
• Questions for Our Panel of Experts

Our Panel of Experts

Danny Markabawi, MD

Assistant Professor of Medicine, Breast Medical Oncology, Cooper Medical School of Rowan University

Hong (Amy) Zhang, MD, PhD

Attending Pathologist, Breast Pathologist, Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center

Kara R. (Schoeffel) Rogen, MS, CGC

Licensed Certified Genetic Counselor, Department of Clinical Genomics, Mayo Clinic

Jennifer LaPietra, MSW

Oncology Social Worker, Patient Assistance Program Manager, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 02, 2026.